Jump to content
Wikipedia The Free Encyclopedia

MRS8209

From Wikipedia, the free encyclopedia

Pharmaceutical compound
MRS8209
Identifiers
  • 4-[6-(cyclopentylamino)-2-iodopurin-9-yl]-2,3-dihydroxybicyclo[3.1.0]hexane-1-carbonitrile
Chemical and physical data
Formula C17H19IN6O2
Molar mass 466.283g·mol−1
3D model (JSmol)
  • O[C@H]1[C@@H](O)[C@@H]([C@H]2C[C@]21C#N)n1cnc2c1nc(I)nc2NC1CCCC1

MRS8209 is an experimental drug which acts as a potent, peripherally selective 5-HT2B receptor antagonist with high selectivity over other serotonin receptor subtypes. It has been investigated for possible applications in the treatment of heart and lung fibrosis and intestinal or vascular conditions mediated by 5-HT2B, while sparing 5-HT2B mediated activity in the brain.[1]

See also

[edit ]

References

[edit ]
  1. Tosh DK, Pavan M, Clark AA, Lammers J, Villano S, Marri S, et al. (December 2024). "Potent and Selective Human 5-HT2B Serotonin Receptor Antagonists: 4'-Cyano-(N)-methanocarba-adenosines by Synthetic Serendipity". Journal of Medicinal Chemistry. 67 (23): 21264–21291. doi:10.1021/acs.jmedchem.4c02174. PMC 11715225 . PMID 39589936.



Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information.

AltStyle によって変換されたページ (->オリジナル) /